A popular weight loss drug has become the first FDA-approved prescription medication to treat obstructive sleep apnea. Sleep apnea can cause a host of health problems, including the inability to lose ...

New research shows Ozempic may reduce sleep apnea severity by over 50%. Here's what the science actually says.

The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...

* Zepbound approved for treating obstructive sleep apnea in adults with obesity * Significant reduction in apnea hypopnea index observed after 52 weeks of //use * Weight loss achieved with Zepbound ...

Medicare drug plans can now cover Eli Lilly & Co.’s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that’s expected to prove a big boost for the drug company. The U.S. Food and ...

Zepbound is an injectable prescription medication created to help adults with obesity and weight-related problems, including obstructive sleep apnea. OSA causes airway collapses during sleep and ...

Zepbound, Eli Lilly’s weight loss medication, became the first FDA-approved drug for obstructive sleep apnea Dec. 20. The new indication is for obese adults who experience moderate to severe ...

Dec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleep apnea. The agency ...

(CNN) — The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of the class known as ...

The U.S. Food and Drug Administration has approved Eli Lilly and Co.’s obesity-treatment Zepbound as the first medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. Lilly ...